Target intelligence / Profile preview

Host mucosal and immune environment

Molecular classification
Other
01

Overview

The host mucosal and immune environment is a specialized physiological system comprising the epithelial barriers and underlying immune components of the respiratory, gastrointestinal, and urogenital tracts (Mowat & Agace, 2014, Nature Reviews Immunology). It serves as the primary interface between the host and the external world, balancing the need for nutrient absorption or gas exchange with the necessity of defending against pathogens (Peterson & Artis, 2014, Nature Reviews Immunology). This environment includes the mucosa-associated lymphoid tissue (MALT), which contains a diverse array of immune cells such as T cells, B cells, and dendritic cells, as well as biochemical defenses like secretory IgA and antimicrobial peptides (Brandtzaeg, 2011, Trends in Immunology). Dysregulation of this environment, characterized by a breakdown in barrier integrity or a loss of immunological tolerance to commensal microbes, is a hallmark of diseases such as inflammatory bowel disease, celiac disease, and chronic obstructive pulmonary disease (Neurath, 2014, Nature Reviews Immunology). Pharmacological intervention in this environment typically involves the use of biologics to block specific inflammatory pathways, such as TNF-alpha or integrins, or anti-inflammatory agents to restore homeostasis and promote mucosal healing (Feagan et al., 2013, New England Journal of Medicine).

Other names
Mucosal immune systemMucosa-associated lymphoid tissueMALTMucosal barrierGastrointestinal immune environmentMucosal homeostasis
02

Mechanism of action

Modulation of leukocyte trafficking to mucosal sites, neutralization of pro-inflammatory cytokines, stabilization of the epithelial barrier, and induction of immunological tolerance.

03

Biological functions

Immune responseBarrier functionHomeostasisPathogen defenseTolerance inductionAntigen sampling
04

Disease associations

InflammationInfectionInflammatory bowel diseaseAsthmaAllergyCeliac diseaseChronic obstructive pulmonary disease
05

Safety considerations

Increased risk of opportunistic infectionsImpaired mucosal healingDisruption of the commensal microbiomeLoss of oral toleranceSystemic immunosuppression
06

Interacting drugs

Vedolizumab

7 more in the full profile.

07

Biomarkers

Fecal calprotectinSecretory IgAC-reactive proteinMucosal cytokine profilesZonulin

Beyond the preview

Go deeper on Host mucosal and immune environment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host mucosal and immune environment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call